199 related articles for article (PubMed ID: 24924305)
1. Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.
Boros-Majewska J; Salewska N; Borowski E; Milewski S; Malic S; Wei XQ; Hayes AJ; Wilson MJ; Williams DW
Med Microbiol Immunol; 2014 Oct; 203(5):341-55. PubMed ID: 24924305
[TBL] [Abstract][Full Text] [Related]
2. Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei.
Brautaset T; Sletta H; Nedal A; Borgos SE; Degnes KF; Bakke I; Volokhan O; Sekurova ON; Treshalin ID; Mirchink EP; Dikiy A; Ellingsen TE; Zotchev SB
Chem Biol; 2008 Nov; 15(11):1198-206. PubMed ID: 19022180
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Sardi JC; Gullo FP; Freires IA; Pitangui NS; Segalla MP; Fusco-Almeida AM; Rosalen PL; Regasini LO; Mendes-Giannini MJ
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):387-391. PubMed ID: 27638348
[TBL] [Abstract][Full Text] [Related]
4. Nystatin-like Pseudonocardia polyene B1, a novel disaccharide-containing antifungal heptaene antibiotic.
Kim HJ; Han CY; Park JS; Oh SH; Kang SH; Choi SS; Kim JM; Kwak JH; Kim ES
Sci Rep; 2018 Sep; 8(1):13584. PubMed ID: 30206268
[TBL] [Abstract][Full Text] [Related]
5. New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei.
Brautaset T; Sletta H; Degnes KF; Sekurova ON; Bakke I; Volokhan O; Andreassen T; Ellingsen TE; Zotchev SB
Appl Environ Microbiol; 2011 Sep; 77(18):6636-43. PubMed ID: 21764946
[TBL] [Abstract][Full Text] [Related]
6. A novel in vitro assay for assessing efficacy and toxicity of antifungals using human leukaemic cells infected with Candida albicans.
Boros-Majewska J; Turczyk Ł; Wei X; Milewski S; Williams DW
J Appl Microbiol; 2015 Jul; 119(1):177-87. PubMed ID: 25845720
[TBL] [Abstract][Full Text] [Related]
7. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
8. The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans.
Biernasiuk A; Berecka-Rycerz A; Gumieniczek A; Malm M; Łączkowski KZ; Szymańska J; Malm A
Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6355-6367. PubMed ID: 34410437
[TBL] [Abstract][Full Text] [Related]
9. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
[TBL] [Abstract][Full Text] [Related]
10. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of alpha-mangostin against Candida albicans.
Kaomongkolgit R; Jamdee K; Chaisomboon N
J Oral Sci; 2009 Sep; 51(3):401-6. PubMed ID: 19776506
[TBL] [Abstract][Full Text] [Related]
12. Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.
Tonon CC; Francisconi RS; Bordini EAF; Huacho PMM; Sardi JCO; Spolidorio DMP
Braz Dent J; 2018; 29(4):359-367. PubMed ID: 30462762
[TBL] [Abstract][Full Text] [Related]
13. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA
Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267
[TBL] [Abstract][Full Text] [Related]
14. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
[TBL] [Abstract][Full Text] [Related]
15. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
[TBL] [Abstract][Full Text] [Related]
16. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
[TBL] [Abstract][Full Text] [Related]
17. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of coronarin D against Candida albicans.
Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
[TBL] [Abstract][Full Text] [Related]
19. Chemical modification and biological evaluation of new semisynthetic derivatives of 28,29-Didehydronystatin A1 (S44HP), a genetically engineered antifungal polyene macrolide antibiotic.
Preobrazhenskaya MN; Olsufyeva EN; Solovieva SE; Tevyashova AN; Reznikova MI; Luzikov YN; Terekhova LP; Trenin AS; Galatenko OA; Treshalin ID; Mirchink EP; Bukhman VM; Sletta H; Zotchev SB
J Med Chem; 2009 Jan; 52(1):189-96. PubMed ID: 19055412
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.
Wong SS; Kao RY; Yuen KY; Wang Y; Yang D; Samaranayake LP; Seneviratne CJ
PLoS One; 2014; 9(1):e85836. PubMed ID: 24465737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
